US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

ERISA Recap: 6 Important Rulings From July No Photo Available

Kellie Mejdrich

The Ninth Circuit rejected a fund manager's bid to force arbitration in a 401(k) suit, a district court tossed a pension de-risking su... (more story)

This Week's Healthcare Earnings: Pfizer, Cigna And More No Photo Available

Yeji Jesse Lee

Major companies across the pharmaceutical and insurance industries posted their second quarter results this past week. Law360 looks at... (more story)

HHS Disclosures, Trans Care Bar Targeted In New Suits No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at new suits filed over the past week, including challenges to the U.S. Department of Health and Hum... (more story)